Based on this, we hypothesized that TRIM22 may similarly regulate ESCC proliferation, metastasis, and invasion via the JAK2/STAT3 pathway, which is also involved in the TRIM22-mediated inhibition of viral replication [24]. Here, JAK2 is linked to esophageal squamous cell carcinoma.